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Abstract
Louis Pasteur (1822–1895) is an exceptional scientist who opened a new era in medicine and biology. Starting from studies on crys-
tals of by-products of wine fermentation, he first defined a distinct chemistry between dead and living matters. He then showed
the role of living microbes in the fermentation and putrefaction processes. This brought him to challenge the two-millennium-old
theory of spontaneous generation, using remarkably well-designed experiments. His observations on epidemics in silkworms allowed
him to demonstrate the role of specific germs in infectious diseases. His discovery of the vaccine against fowl cholera can be con-
sidered as the birth of immunology. Finally, he became universally recognized through his famous vaccinations against anthrax and
rabies.
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Louis Pasteur is probably one of the most famous scien-
tists in the world, universally recognized as a benefactor
of Humanity [1–4]. His name is associated with many new
concepts and discoveries, such as the crystals of life, the
theory of germs, and vaccination. Apparently, nothing pre-
destined this man of humble origin to become a giant in
the field of medicine and biology, to such a point that he
opened up a new era and saved countless lives. Indeed,
he came into the world during an exciting and tumultous
period of history, following the French Revolution, a time
of great discoveries in science and medicine. Pasteur was
born in December 1822, in the small city of Dole situated
in the eastern region of France. His father, who had
served as a sergeant in Napoleon’s army, opened a tan-
nery on his return home. As a schoolboy, Pasteur was a
serious, not particularly brilliant child, but diligent and
wishing to fulfil his father’s dream, namely to become a
school teacher! Although he was a talented painter and
artist, he decided to pursue studies in scientific disciplines
(Fig. 1).
Crystals of life 1847
In 1843, Louis Pasteur was admitted, through a highly com-
petitive examination, to the Ecole Normale Supe´rieure in Paris,
a training school for the professors of colleges. There, he
specialized in the physics and chemistry departments and, as
a chemist, became interested in the origins of life. Pasteur
decided to work in the field of crystals to achieve his doc-
torate. While still young, he accomplished a great feat in
working on the optical activity of crystals in response to
polarized light, using tartaric acid and tartrates derived from
fermentation. Wine fermentation is known to generate ‘tar-
tar’, by-products mainly constituted by large crystals of tar-
taric acid. These crystals are optically active and rotate
polarized light. Smaller crystals, needle-like tufts, are some-
times present, as another form of tartaric acid, designated as
paratartaric acid or racemic. According to the German
chemist Eilhard Mitscherlich, these crystals are optically inac-
tive, although they display the same chemical composition,
shape and refraction. For Pasteur, this was impossible. He
became convinced that these components must exhibit some
chemical differences, which might be expressed in the
crystals’ shape. He therefore prepared crystals of 19 differ-
ent salts of tartrates and paratartrates, which he examined
under the microscope. He detected small facets with differ-
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ent orientation according to the crystals. The facets in each
of the tartrate salts had the same orientation. In contrast,
some facets of each paratartrate salt were oriented in one
direction but others were in the opposite direction: there
was a mixture of crystals. He manually separated the right
and the left crystals, which were identical in shape to
crystals of tartrate salts. The optical inactivity to rotate the
polarized light was therefore explained by the mixture of
paratartrate crystals. He presented his research thesis in
1847.
Pasteur made his first step toward biology by chance,
several years later, while working in Strasbourg in 1857.
During the summer, he observed that certain fungi grew
readily in solutions of calcium paratartrate, which were
composed equally of left and right crystals. He found that
the contaminated solutions became optically active with
time, as the right component was consumed by fungi. This
was a new way of separating paratartrate crystals! For
Pasteur, only living agents could produce optically active
asymmetric compounds. This was the only sharp defined
difference between the chemistry of dead and living matter
[5].
The end of the theory of the spontaneous
generation 1857–1873
Pasteur became progressively interested in the process of
fermentation that produces the crystals of life. What was the
nature of fermentation? At that time, the prevailing paradigm
was that fermentation was a chemical catalytic process due
to ‘ferments’. Naturalists described under the microscope
the presence of numerous yeasts always accompanying the
alcoholic fermentation. It was largely believed that these
yeasts were nothing but a complex chemical substance,
acting as a catalyst in the conversion of sugars into alcohol.
Various other ‘ferments’ (e.g. lactic acid, acetic acid) were
also considered as complex material acting as catalyst, purely
by chemical contact. This view was strongly supported by
most eminent chemists, such as Justus von Liebig, Jo¨ns Ber-
zelius and Friedrich Wo¨hler. However, an alternative hypoth-
esis emerged, claiming that ferments were living microbes. In
1835, Charles Cagniard-Latour, followed by Theodor Schw-
ann and Friedrich Ku¨tzing in 1837, demonstrated that fer-
mentation started with the presence of yeasts, progressed
with their multiplication, and stopped when yeast growth
was over [6,7]. These authors concluded that yeasts were
living cells multiplying during the fermentation process. In
addition, heating and antiseptics, for example heavy metals
such as arsenic, stopped the process of fermentation. The
hypothesis claiming that fermentation was a living process
was rejected by most chemists.
While working in Lille, Pasteur became involved in this
controversy (Fig. 2). He was approached by an industrialist
who had encountered difficulties with the production of
alcohol by the fermentation of beer. In many cases, alcohol
was contaminated with undesirable substances during the
course of fermentation for unknown reasons. Pasteur per-
formed many tests in the factory, trying to understand the
cause of beer ‘disorders’. Under the microscope, he
observed the presence of small globules in the fermenting
juice, associated with fine structures smaller than yeasts,
which turned out to be bacteria. With his polarimeter, he
also found that the fermented juice was optically active. He
also succeeded in isolating an optically active component,
identified as amyl alcohol. This substance clearly could not
derive from the degradation of ethyl alcohol. Pasteur was
then convinced that the process of fermentation was caused
by the activity of living ferments: ‘The chemical act of fer-
mentation is essentially a phenomenon correlative with a
vital act, beginning and ending with the latter. I believe that
there is never any alcoholic fermentation without simulta-
neously the organization, development, multiplication of the
globules, or the pursued, continued life of globules which are
already formed’. In 1857, he published a work on lactic fer-
mentation that can be considered as the landmark of future
germ theory [8]. From 1857 to 1873 he studied many fer-
mentations, such as those of sour milk, wine, beer and vine-
gar. He concluded that all fermentation processes are due to
specific living ferments (bacteria or yeasts). Wine and beer
FIG. 1 The young Louis Pasteur, the ‘Angel of Science’.
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disorders were caused by contaminant bacteria [9,10]. He
discovered life without oxygen (anaerobic life of the butyric
fermentation) and proposed a prophylactic treatment of dis-
eases: iterative heating or pasteurization [11]. These findings
led him to study the hypothesis of spontaneous generation.
Since Aristotle (sixth century BC), it had been generally
believed that the metamorphosis and decomposition phe-
nomena, such as decay, putrefaction, rotting, fermentation
and mouldering, resulted from a ‘vital force’ existing within
the organic substances. Many living things came forth from
non-living matters because the non-living material contained
pneuma or ‘vital heat’. This theory of the spontaneous gen-
eration of living creatures was still prevailing in Pasteur’s
time, despite remarkable experimental and premonitory
works by the Italians Francesco Redi (1626–1697) and Lazz-
aro Spallanzani (1729–1799) [12]. Using well-designed experi-
ments, Spallanzani had produced evidence in 1765 for the
preventive role of heating on broth infusions, suggesting that
the air was a source of contamination of the culture broth.
Pasteur reproduced these experiments using yeast infusions
(1861–1865). These data were challenged by the naturalist
and biologist Felix Archime`de Pouchet (1800–1872), who
failed to reproduce Pasteur’s results using hay infusions. This
was the origin of a heated controversy before the French
Acade´mie des Sciences [12–14]. Pasteur designed wonderful
experiments with heating to support his results. He even
succeeded in preserving sterility without heating using
swan-neck flasks and cotton filters: indeed, he brought solid
evidence that the air contains microbes that contaminate
broth cultures. This marked the end of the two-millennium-
old theory of spontaneous generation.
The germ theory of infectious diseases
Since Antiquity, the origin of epidemics had remained myste-
rious. It was generally accepted that these phenomena were
related to miasmas, involving the influence of weather and
planets. During the nineteenth century, several observations
pointed out the role of germs as a possible cause of epidem-
ics. First, work by the Italian Agostino Bassi published in
1835 on the ‘white muscardine’, an epidemic disease of
domesticated silkworms (mal del segno), which became pro-
gressively covered by a cotton-like duvet. Bassi observed
under the microscope that a fungus (Botrytis bassiana) multi-
plied in and devoured the silkworms’ bodies. He concluded
that the fungus was the cause of the disease. He efficiently
used a prophylaxis based on hygiene measures and phenol
solution to prevent the fungal spread. A few years later in
1845–1847, another fungus was stigmatized as the agent of
‘Potato Blight’, a terrible epidemic of crops in Ireland. Fol-
lowing several rainy summers in Ireland the potato crops
were entirely destroyed. As this was the only food source
for the population, the ‘Great Irish Famine’ occurred with
1 million dead of starvation and 1.5 million migrating, out of
a population of 8 million. In 1846, the Reverend Miles J.
Berkeley observed that the potato tubers and leaves were
massively invaded by a microscopic fungus, termed Phytoph-
thora infectans. In an article entitled ‘Observations, Botanical
and Physiological, on the Potato Murrain’, he assumed that this
fungus was responsible for the destruction of crops. This
hypothesis was experimentally proven in 1863 by the Ger-
man botanist Heinrich Anton de Barry (1831–1888), who
inoculated spores of P. infestans on healthy potato leaves and
observed the subsequent growth of mycelium and the
appearance of the characteristic black spots of potato blight
[12].
There were also early observations in patients that sug-
gested the role of fungi in communicable diseases. In 1839,
the dermatologist Johann Schoe¨nlein showed that tinea fav-
osa, a cutaneous mycosis widely spread in the population,
was caused by Trichophyton schoenleinii. Soon afterwards, The-
odor Berg, David Gruby and K.F. Eichstedt demonstrated
the role of specific fungi in various mycoses, including thrush
(candidiasis), tinea and pityriasis versicolor [12].
In 1847, Ignaz Semmelweis (1818–1865), a young medi-
cal doctor working at the Vienna General Hospital,
FIG. 2 Louis Pasteur, at the time of his studies on fermentation.
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noticed that the mortality from childbed fever was higher
in the maternity clinic of Prof. Johann Klein (18%), com-
pared with that of the nearby maternity clinic run by Prof.
Franz Bartsch (3%). He suspected that puerperal fever
could be transmitted by the medical students performing
autopsies: ‘The causation I search is inside our clinic: it is on
the fingers of students’. He prevented the spreading of invisi-
ble particles by hand washings with chlorinated lime, so suc-
cessfully reducing mortality. He summarized his work in 1861
in a famous book entitled Etiology, Concept and Prophylaxis of
Childbed Fever [15,16].
Pasteur became involved in the field of infectious diseases
through an epidemic in silkworms in the south of France
(1865–1870). In 1853, a mysterious disease, called ‘pe´brine’,
began to attack the French silkworm nurseries (‘magnaner-
ies’). Silkworm larvae, which normally feed on mulberry
leaves, became covered in brown dots, like pepper seeds,
and were unable to spin silkworm thread. By 1865, the dis-
ease spread to most silkworm-producing areas, and the
industry was nearly ruined in France, as in the rest of wes-
tern Europe. A closely related form of this disease, known
as ‘flacherie’ (variants are also known as ‘morts-flats’, ‘gattine’)
was also described. Flacherie (or ‘flaccidness’) was character-
ized by dark brown silkworms. The Academician Jean-Bap-
tiste Dumas asked Pasteur to work on this disease. He went
to Ale`s, a small city in the south of France, in the heart of
the silkworm district in the Cevennes. He studied this dis-
ease from 1865 to 1870 and established that there were two
entirely different diseases, previously considered as variants
of the same disease. One was ‘pe´brine’ caused by the parasite
protozoan (Nosema bombycis), and the other was flacherie,
which was believed by Pasteur to be primarily nutritional in
origin, with bacterial intestinal proliferation. It is known
today that flacherie is the result of a virus with intestinal bac-
terial superinfection. He proposed an effective prophylaxis
based on the selection of non-infected eggs by microscopic
examination [1–4]. Then, Pasteur proposed the germ theory
to explain all infectious diseases. A Scottish surgeon, Joseph
Lister (1827–1912), reading Pasteur’s works, was convinced
that suppurated wounds and gangrene were the result of
contaminant bacteria. In 1867, he confirmed Pasteur’s con-
clusions with his own experiments using antiseptics such as
phenol to successfully treat wounds.
The germ theory had important consequences. First, it
triggered a hunt for pathogens: within 20 years, the bacteria
responsible for most infectious diseases were discovered,
such as leprosy, tuberculosis, diphtheria, cholera, bubonic
plague, following which new methods to prevent spread of
epidemics appeared, including hygiene, pasteurization and
vaccines.
Discovery of vaccines 1877–1895
The discovery by Louis Pasteur of the vaccine against fowl
cholera can be considered as the birth of immunology [17].
This endemic disease spread via devastating epidemics, rap-
idly destroying the breeding of chickens. Thousands of chick-
ens, packed into hen houses, were dying of diarrhoeal
disease within 48 h. In 1878, Pasteur succeeded in culturing
the causative agent of fowl cholera, a highly virulent bacte-
rium, Pasteurella multocida, and the disease was easily repro-
duced by inoculation. In 1879, Pasteur observed by chance
that ‘old’ cultures lost their virulence. Chickens inoculated
with old cultures became protected against a virulent wild
strain and survived. Interestingly, the few chickens surviving
the disease still excreted virulent bacteria, so indicating the
existence of healthy carriers, an important concept to
explain the mysterious spread of germs during epidemics. In
February 1880, Pasteur presented his results to the French
Acade´mie des Sciences, in a memorandum entitled ‘Sur les mal-
adies virulentes et en particulier sur la maladie appele´e vulgaire-
ment chole´ra des poules’ (‘On virulent diseases and
particularly on the disease commonly called fowl cholera’)
[18]. He coined the phenomenon ‘vaccination’, in honour of
Edward Jenner (1749–1823), who had performed the first
inoculation of cowpox to prevent smallpox in 1796.
Pasteur then became interested in the prevention of
anthrax, a widely spread plague of cattle [19,20]. In 1874, a
rural physician, Robert Koch (1843–1910), demonstrated the
role of Bacillus anthracis in this disease, and succeeded in pre-
serving its pathogenicity after eight subcultures. He also dis-
covered the resistant spores of this bacterium. Pasteur
confirmed its causative role by subculturing this bacterium
one hundred times, without altering the high virulence of the
pathogen. Then, he tried in 1881 to attenuate its virulence
by preventing spore formation. This was achieved by main-
taining live bacilli in the presence of oxygen. In optimal con-
ditions, live bacilli were grown for 8 days in ventilated
culture broth incubated at 42–43C. Bacilli progressively lose
their virulence, becoming harmless in animals, such as rab-
bits, sheep and guinea-pigs. The protocol of vaccination was
more effective when inoculating an attenuated culture, fol-
lowed 12 days later by a more virulent culture (March
1881). Pasteur finally used another attenuation procedure
with potassium bichhromate, followed by three passages in
mice to reinforce the attenuated strain, according to a pro-
tocol by Jean-Joseph Toussaint. Then, Hippolyte Rossignol, a
veterinarian from Melun, asked Pasteur to perform public
experiments in the field. He accepted. A risky demonstration
of the efficacy of vaccine! On 5 May 1881 at Pouilly-le-Fort,
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a small village near Paris, he inoculated an attenuated culture
into 24 sheep, one goat and six cows. On 17 May he
injected a more virulent culture. Vaccinated animals and a
control group were challenged on 31 May with a highly viru-
lent culture. On 2–3 June, all sheep and the goat from the
control group died, and the cows, which had received the
same challenge, were very ill. In contrast, all the vaccinated
animals survived in good health. The triumph of Pasteur was
acclaimed by an enormous crowd and many reporters. In
1882, 85 000 cattle were vaccinated and in 1894 almost
3.4 million, so reducing anthrax mortality to 0.3% of the
French livestock.
Shortly afterwards, Pasteur was called to study a disas-
trous epidemic of swine erysipelas in the Vaucluse, in the
south of France. In March 1883 he identified the culprit as a
highly virulent bacterium, now called Erysipelothrix rhusiopa-
thiae. He then designed a new vaccine against this disease, by
iterative passages through rabbits, an unrelated resistant
animal species. This attenuated vaccine was then widely used.
From 1886 to 1892, more than 100 000 pigs were vacci-
nated in France.
Vaccination against rabies in 1885 was the last discovery
by Louis Pasteur that immortalized him (Fig. 3). Pasteur was
63 years old, handicapped by a permanent paralysis of his left
arm as the sequel of a cerebral haemorrhage. In 1879, Pierre
Galtier, a French veterinarian working in Lyon, demonstrated
that rabies could be transmitted to rabbits by dog saliva. In
1880, Pasteur started studying rabies and succeeded in trans-
mitting the disease to rabbits by intracerebral inoculation of
brain extracts. The disease occurred after 1–2 weeks,
instead of several weeks or months following bites. He found
that virulence was exacerbated through iterative passages on
rabbit brains shortening the incubation time to 6 days, with a
rapidly fatal disease in dogs. This virulent strain was called
‘fixed virus’. In 1884, Pasteur successfully attenuated the vir-
ulence of fixed virus by passages from dogs to monkeys, so
increasing the incubation time for dogs, rabbits and guinea-
pigs. Animals receiving the monkey virus were protected
against the highly virulent fixed virus. Taking advantage of
the long period of incubation of rabies, he then thought to
use the attenuated vaccine as a therapy to stimulate the
resistance of patients, i.e. the immune response. In 1885,
with Emile Roux, Pasteur designed a new process to attenu-
ate the fixed virus. Rabbit spinal cords infected with the
fixed virus were desiccated and long-exposed to air in glass
flasks. In these conditions, the virus lost its virulence in
15 days. By daily injections of rabbit spinal cord emulsions,
progressively less and less attenuated, he could protect dogs
against the highly virulent virus, including those inoculated by
the intracerebral route [18–20].
Then, Fate knocked at Pasteur’s door. On 6 July 1885,
Joseph Meister, a 9-year-old boy, came from Alsace to con-
sult Dr Joseph Grancher at the Hoˆpital des Enfants-malades in
Paris. He had been severely bitten by a rabid dog at the
hands, legs and hips. The physician convinced a reluctant Pas-
teur to vaccinate the boy because he was inevitably going to
die: it was the only way for him to stand a chance of survival!
The treatment started on 7 July, 60 h after the accident. The
boy received 12 consecutive injections of extracts of rabbit
spinal cords attenuated by a 14-days desiccation procedure.
On 16 July 1885, he was inoculated with a spinal cord extract
from a rabbit dead of infection induced by the fixed virus.
Joseph Meister survived; Pasteur had performed the first
therapeutic vaccination to cure a universally lethal disease. In
October 1885, Jean-Baptiste Jupille, a 15-year-old shepherd
from the Jura, in the east of France, was severely bitten by a
rabid dog. He too was successfully protected by vaccination.
In October 1886, more than 2490 patients were vaccinated
at the Pasteur laboratory, in Paris. Only ten died out of 1726
French patients [1,2]. In the same time, an investigation
revealed mortality of about 40% among 320 unvaccinated
patients bitten by rabid animals. After vaccination, mortality
fell to 0.5% [19–21]. This universal triumph of anti-rabies vac-
cination contributed to the creation of the Pasteur Institute
in 1888. Louis Pasteur set three objectives for the new Insti-
tute: ‘It must be a public dispensary to treat rabies, a research
FIG. 3 Louis Pasteur, at the time of the vaccine against rabies.
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centre for infectious diseases, and a teaching centre for stud-
ies on microbiology’. This exceptional scientist, observer, skil-
ful experimenter, and imaginative philosopher died in 1895,
after opening a new era in medicine and biology.
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